Aakaar Medical Technologies IPO Subscribed 2.28x on Day 3

Aakaar Medical Technologies IPO subscribed over 2.28x on its Last day of subscription, wherein QIB subscribed 3.51x, NII subscribed 1.48x, and RII subscribed 1.93x.

Table of Contents

Aakaar Medical Technologies’ IPO subscription started on Friday, June 20, 2025, and will close on June 24, 2025, as per the schedule. The price band is set at ₹68 to ₹72 per share with a face value of ₹10. 

Aakaar Medical Technologies IPO Subscription Status

Aakaar Medical Technologies IPO subscribed over 2.28x on its Last day till 05.00 PM on 24th June 2025.

  • Aakaar Medical Technologies IPO subscription QIB investors portion is 3.51x times, while NII subscribed 1.48x times, and RII investors subscribed 1.93x times.  
  • The company has received bids for 57,00,800 shares against 24,96,000 shares on offer on the Last day. 
  • Aakaar Medical Technologies’ IPO subscribed over 0.68x times on day 2.
  • Aakaar Medical Technologies’ IPO subscribed over 0.37x times on day 1.

About Aakaar Medical Technologies IPO

Incorporated in 2013, Aakaar Medical Technologies Ltd. is one of the leading medical companies that focuses on providing a wide range of aesthetic and specialized cosmetic products and devices. The company is known to offer specialty products for Dermatologists, Plastic Surgeons, Aesthetic Physicians, and Cosmetologists. The company’s portfolio comprises both its own products and internationally produced devices obtained from various countries such as South Korea, Spain, Italy, and Austria, serving its products and devices to dermatologists, plastic surgeons, and aesthetic physicians, who sell to customers or use them in various treatments. The company’s product range consists of Homecare and professional skin care, Injectable and contouring, Homecare for skin, Professional Hair Care, Professional Skincare products, Hair Growth Serum & Tablets, Medifacial Kit, Device for urinary incontinence, Tattoo removal, pigmentation, and skin rejuvenation devices, Laser Hair Reduction devices and Hair Transplant Device. As of now, the company consists of a team of 90 trained engineers and salespeople. Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu are some of the major states where the company sells its products.

Aakaar Medical Technologies IPO Company Financial Report

The company reported revenue of ₹61.76 crores in 2025 against ₹46.27 crores in 2024. The company reported a profit of ₹6.04 crores in 2025 against a profit of ₹2.87 crores in 2024.

Aakaar Medical Technologies IPO GMP

Aakaar Medical Technologies’ IPO GMP was ₹0 as of Tuesday, 24th June. That indicates the IPO is trading at ₹72 with a ₹0 premium in the grey market against the issue price of ₹72.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.